2011Journal of Practical Traditional Chinese Internal MedicineRequires access

Treating 36 Cases of Diabetic Peripheral Neuropathy by Qingzao Decoction plus Mecobalamin

Yanying Li

Open publisher page 0 citations

Abstract

[Objective]To observe the effect of diabetic peripheral neuropathy by Qingzao decoction plus mecobalamin.[Method]68 patients with DPN were randomly divided into treatment and control groups,based on the basic treatment in the control group only received oral Mecobalamin,treatment group to Qingzao decoction plus mecobalamin treatment.Both groups were observed after 8 weeks treatment.[Results]Treatment group and control group before and after comparison,the median nerve,peroneal nerve motor conduction velocity(MCV),sensory conduction velocity(SCV) and latency(Lat),the differences were significant(P 0.01,P0.05).Treatment group and control group after treatment,median nerve,peroneal nerve MCV,SCV and latency(Lat) comparison,the differences were significant(P 0.01,P 0.05).Clinical efficacy of the treatment group compared with the control group,the difference was significant(P 0.05).[Conclusion]Qingzao decoction plus mecobalamin treating DPN has a good clinical effect.

About this research paper

What this paper is about

[Objective]To observe the effect of diabetic peripheral neuropathy by Qingzao decoction plus mecobalamin.[Method]68 patients with DPN were randomly divided into treatment and control groups,based on the basic treatment in the control group only received oral Mecobalamin,treatment group to Qingzao decoction plus mecobalamin treatment.Both groups were observed after 8 weeks treatment.[Results]Treatment group and control group before and after comparison,the median nerve,peroneal nerve motor conduction velocity(MCV),sensory conduction velocity(SCV) and latency(Lat),the differences were significant(P 0.01,P0.05).Treatment group and control group after treatment,median nerve,peroneal nerve MCV,SCV and latency(Lat) comparison,the differences were significant(P 0.01,P 0.05).Clinical efficacy of the treatment group compared with the control group,the difference was significant(P 0.05).[Conclusion]Qingzao decoction plus mecobalamin treating DPN has a good clinical effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To observe the effect of diabetic peripheral neuropathy by Qingzao decoction plus mecobalamin.[Method]68 patients with DPN were randomly divided into treatment and control groups,based on the basic treatment in the control group only received oral Mecobalamin,treatment group to Qingzao decoction plus mecobalamin treatment.Both groups were observed after 8 weeks treatment.[Results]Treatment group and control group before and after comparison,the median nerve,peroneal nerve motor conduction velocity(MCV),sensory conduction velocity(SCV) and latency(Lat),the differences were significant(P 0.01,P0.05).Treatment group and control group after treatment,median nerve,peroneal nerve MCV,SCV and latency(Lat) comparison,the differences were significant(P 0.01,P 0.05).Clinical efficacy of the treatment group compared with the control group,the difference was significant(P 0.05).[Conclusion]Qingzao decoction plus mecobalamin treating DPN has a good clinical effect.

Key concepts: Medicine, Decoction, Nerve conduction velocity, Peripheral neuropathy, Nerve conduction, Clinical efficacy, Significant difference, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Treating 36 Cases of Diabetic Peripheral Neuropathy by Qingzao Decoction plus Mecobalamin — Research Paper | ScholarLens